The Art of HIV Elimination: Past and Present Science.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of AIDS and Clinical Research

• Publication date

  2015-11-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.4172/2155-6113.1000525PMID 27774350PMCID PMC5072486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

  2016cited by this paper
• HPTN 068: A Randomized Control Trial of a Conditional Cash Transfer to Reduce HIV Infection in Young Women in South Africa—Study Design and Baseline Results

  2016cited by this paper
• A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

  2015cited by this paper
• Defeating AIDS--advancing global health.

  2015cited by this paper
• Tenofovir-based preexposure prophylaxis for HIV infection among African women.

  2015cited by this paper
• Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

  2015cited by this paper
• HPTN 071 (PopART): Rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment – a study protocol for a cluster randomised trial

  2014cited by this paper
• Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiation

  2014cited by this paper
• Antiretroviral therapy for the prevention of HIV transmission: what will it take?

  2014cited by this paper
• Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention.

  2014cited by this paper
• Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study.

  2014cited by this paper
• Effect of community-based voluntary counselling and testing on HIV incidence and social and behavioural outcomes (NIMH Project Accept; HPTN 043): a cluster-randomised trial.

  2014cited by this paper
• Cross-Sectional Study of Genital, Rectal, and Pharyngeal Chlamydia and Gonorrhea in Women in Rural South Africa

  2014cited by this paper
• Antiretroviral therapy to prevent HIV transmission in serodiscordant couples in China (2003-11): a national observational cohort study.

  2013cited by this paper
• High-Levels of Acquired Drug Resistance in Adult Patients Failing First-Line Antiretroviral Therapy in a Rural HIV Treatment Programme in KwaZulu-Natal, South Africa

  2013cited by this paper
• Elimination of HIV in South Africa through Expanded Access to Antiretroviral Therapy: A Model Comparison Study

  2013cited by this paper
• High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa

  2013cited by this paper
• Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples (Review)

  2013cited by this paper
• P4.120 Evaluating the Impact of Short Term Financial Incentives on HIV and STI Incidence Among Youth in Lesotho: A Randomised Trial

  2013cited by this paper
• Sexual behaviour in a rural high HIV prevalence South African community: time trends in the antiretroviral treatment era

  2013cited by this paper
• Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples.

  2013cited by this paper
• New Approaches to Antiretroviral Drug Delivery: Challenges and Opportunities Associated with the Use of Long-Acting Injectable Agents

  2013cited by this paper
• Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine.

  2013cited by this paper
• Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

  2013cited by this paper
• Drug-resistant HIV-1 in sub-Saharan Africa: clinical and public health studies

  2013cited by this paper
• Development of prophylactic vaccines against HIV-1

  2013cited by this paper
• Modeling the within-host dynamics of HIV infection

  2013cited by this paper
• A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in Sub-Saharan Africa

  2013cited by this paper
• Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial

  2013cited by this paper
• Preexposure prophylaxis for HIV infection among African women.

  2012cited by this paper
• Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

  2012cited by this paper
• Effect of a cash transfer programme for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomised trial.

  2012cited by this paper
• Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

  2012cited by this paper
• HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa

  2012cited by this paper
• Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review

  2012cited by this paper
• Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review

  2012cited by this paper
• Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis

  2012cited by this paper
• Combination HIV Prevention: Tailoring and Coordinating Biomedical, Behavioural and Structural Strategies to Reduce New HIV Infections

  2011cited by this paper
• Moving ahead an HIV vaccine: Use both arms to beat HIV

  2011cited by this paper
• HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy

  2011cited by this paper
• Male circumcision and risk of HIV acquisition among MSM

  2011cited by this paper
• Retention in HIV Care between Testing and Treatment in Sub-Saharan Africa: A Systematic Review

  2011cited by this paper
• Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

  2011cited by this paper
• Association of Age with Mortality and Virological and Immunological Response to Antiretroviral Therapy in Rural South African Adults

  2011cited by this paper
• Male circumcision for prevention of heterosexual acquisition of HIV in men.

  2011cited by this paper
• Prevention of HIV-1 infection with early antiretroviral therapy

  2011influential reference
• Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis

  2010cited by this paper
• Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study

  2010cited by this paper
• Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

  2010cited by this paper
• Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

  2010cited by this paper
• HIV Transmission Risk Among Serodiscordant Couples: A Retrospective Study of Former Plasma Donors in Henan, China

  2010cited by this paper
• Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: systematic review

  2010cited by this paper
• Barriers to HIV testing in Europe: a systematic review.

  2010cited by this paper
• Behavioural interventions to reduce HIV risk: what works?

  2010cited by this paper
• Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning?

  2010influential reference
• Factors affecting first-month adherence to antiretroviral therapy amongHIV-positive adults in South Africa

  2010cited by this paper
• Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.

  2010cited by this paper
• Examining the promise of HIV elimination by ‘test and treat’ in hyperendemic settings

  2010cited by this paper
• Decreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinics

  2010cited by this paper
• Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives.

  2010cited by this paper
• The last decade of microbicide clinical trials in Africa: from hypothesis to facts

  2010cited by this paper
• Herpes simplex virus type 2: a key role in HIV incidence.

  2009cited by this paper
• Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

  2009cited by this paper
• Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia

  2009cited by this paper
• Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.

  2009cited by this paper
• Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis

  2009cited by this paper
• The history and challenge of HIV prevention.

  2008cited by this paper
• PERSONNES SEROPOSITIVES NE SOUFFRANT DAUCUNE AUTRE MST ET SUIVANT UN TRAITEMENT ANTIRETROVIRAL EFFICACE NE TRANSMETTENT PAS LE HIV PAR VOIE SEXUELLE

  2008cited by this paper
• Structural approaches to HIV prevention.

  2008cited by this paper
• Behavioural strategies to reduce HIV transmission: how to make them work better.

  2008cited by this paper
• Effect of herpes simplex suppression on incidence of HIV among women in Tanzania.

  2008cited by this paper
• Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment

  2008cited by this paper
• Low effectiveness of syndromic treatment services for curable sexually transmitted infections in rural South Africa

  2008cited by this paper
• Sexual Transmission of HIV-1 Among Serodiscordant Couples in Porto Alegre, Southern Brazil

  2008cited by this paper
• Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial.

  2008cited by this paper
• Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006

  2008cited by this paper
• Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

  2008cited by this paper
• A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy

  2008cited by this paper
• King Kennard Holmes--chair of the Department of Global Health of The University of Washington. Interviewed by Marc Vandenbruaene.

  2007cited by this paper
• Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.

  2007influential reference
• Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in Women: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial

  2007cited by this paper
• King Kennard Holmes—Chair of the Department of Global Health of the University of Washington

  2007cited by this paper
• Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.

  2007influential reference
• Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda

  2006cited by this paper
• Placebocontrolled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 InfectionGurwith M, for the rgp 120 HIV Vaccine Study Group (VaxGen, Brisbane, Calif; et al) J Infect Dis 191:654–665, 2005§

  2006cited by this paper
• Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

  2006cited by this paper
• Adherence to HAART: A Systematic Review of Developed and Developing Nation Patient-Reported Barriers and Facilitators

  2006cited by this paper
• Metaanalysis and Metaregression in Interpreting Study Variability in the Impact of Sexually Transmitted Diseases on Susceptibility to HIV Infection

  2005cited by this paper
• Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial

  2005influential reference
• Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

  2005cited by this paper
• Behavioral Impact, Acceptability, and HIV Incidence Among Homosexual Men With Access to Postexposure Chemoprophylaxis for HIV

  2004cited by this paper
• Adherence to Long-Term Therapies: Evidence for Action

  2003cited by this paper
• Male circumcision for prevention of heterosexual acquisition of HIV in men.

  2003cited by this paper
• Adherence to long-term therapies: evidence for action.

  2003cited by this paper
• Impact of highly active antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco.

  2002cited by this paper
• Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection

  2000cited by this paper
• Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

  2000cited by this paper
• Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis

  2000cited by this paper
• When AIDS became a chronic disease.

  2000cited by this paper
• Structural factors in HIV prevention: concepts, examples, and implications for research

  2000cited by this paper

• Decreasing time to antiretroviral therapy initiation after HIV diagnosis in a clinic‐based observational cohort study in four African countries

  2020cites this paper
• Test but not treat: Community members’ experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa

  2020cites this paper
• Continuing Links Between Substance Use and HIV Highlight the Importance of Nursing Roles

  2017cites this paper
• Commercialised Sexual Exploitation of Children, Adolescents and Women: Health and Social Structure in Bangladesh

  2017cites this paper
• Using geospatial mapping to design HIV elimination strategies for sub-Saharan Africa

  2017cites this paper
• Integration and generalization of “Universal Test and Treat” strategies for HIV in sub-Saharan Africa : The ANRS 12249 TasP Trial and beyond

  2017cites this paper
• Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study

  2017cites this paper
• Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial

  2016cites this paper
• Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men.

  2016cites this paper
• Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa

  2016cites this paper
• Fighting against the Myths among HIV Positive Person

  2016cites this paper
• Community perceptions of repeat HIV-testing: experiences of the ANRS 12249 Treatment as Prevention trial in rural South Africa

  2016cites this paper
• Prevention is better than Cure- AIDS: A Short Review

  2016cites this paper
• HIV Virus: Can it Transmit Through Mosquito Bite. A Small Review

  2016cites this paper
• Prospects of HIV elimination among men who have sex with men: a systematic review of modeling studies

  year unknowncites this paper